Refine by
Drug Delivery Platform Equipment & Supplies
20 equipment items found
Manufactured by:Insulet Corporation based inActon, MASSACHUSETTS (USA)
OmniPod is a unique, automated drug delivery platform that offers improved adherence, outcomes and differentiation throughout a drug’s ...
Manufactured by:LayerBio, Inc based inBoston, MASSACHUSETTS (USA)
OcuRing is a bioerodible sustained-release implant applied to the haptic of an intraocular lens (IOL) for use in cataract surgery. Once implanted inside the eye, the OcuRing continuously releases medications for treatment and prevention of postoperative complications of cataract ...
Manufactured by:EsoCap AG based inBasel, SWITZERLAND
EsoCap owns a unique drug delivery platform allowing the topical application of drug substances for targeted and long-lasting treatment of diseases of the upper gastrointestinal tract for the first ...
Manufactured by:Mediprint Ophthalmics based inSan Diego, CALIFORNIA (USA)
We have proprietary printing technology and ink that allows for the sustained, continuous release of ophthalmic drugs via contact lenses and it is called the MediPrint process. Our unique process results in a novel way to for treat various eye diseases and conditions with a non-invasive, cost-effective treatment. We have an extensive global patent portfolio, comprising intellectual property ...
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
TLC is committed to creating solutions for longstanding challenges in drug development by enabling new therapies with entirely unique properties. TLC has proprietary solution for pharmaceutical product development called LipAD®. LipAD® allows the design of medicines at the nanometer scale, improving drug solubility, protecting molecules from degradation, or targeting drug delivery to ...
by:Theramx Inc. based inSeongnam-si, SOUTH KOREA
Drug delivery platform technology designed to maximize efficacy while simultaneously minimizing side effects of existing drugs by delivery to desired ...
Manufactured by:Windgap Medical, Inc. based inWatertown, MASSACHUSETTS (USA)
The ANDIPEN is a wet/dry dual-chamber autoinjector built to drastically improve temperature resilience and shelf lives of medications traditionally offered and stored in liquid form. The ANDI® Platform is the basis for our epinephrine product, currently in pre-production in partnership with ...
Manufactured by:Windgap Medical, Inc. based inWatertown, MASSACHUSETTS (USA)
This device is supported by an ongoing NIH grant and potential for follow-on ...
Manufactured by:Exparel based inParsippany, NEW JERSEY (USA)
EXPAREL uses proprietary multivesicular liposome (pMVL) technology, an advanced drug delivery platform, to extend analgesia. ...
Manufactured by:Windgap Medical, Inc. based inWatertown, MASSACHUSETTS (USA)
Our thermally stable drug delivery platform will automate rehydration and administration with twice the shelf life and half the size of current anaphylaxis ...
Manufactured by:Skyepharma Production SAS based inSaint-Quentin-Fallavier, FRANCE
Geomatrix® (multi-layer tablet technology) is a well-established, validated and customizable oral drug delivery platform technology that is currently used in 8 products that are commercialized in over 80 countries. Geomatrix® is highly versatile and can be applied to a wide range of different drugs to achieve a variety ...
Manufactured by:Intrommune Therapeutics based inNew York, NEW YORK (USA)
Intrommune has developed a novel drug delivery platform—oral mucosal immunotherapy (OMIT)—for the treatment of food allergies. Therapeutic agents are embedding in fully functioning toothpaste so that treatment can be conveniently administered during a patient’s daily toothbrushing ...
Manufactured by:ApiJect Systems, Corp. based inStamford, CONNECTICUT (USA)
The ApiJect Platform brings together prefilled, single-dose parenterals with scalable, efficient manufacturing to solve drug delivery challenges for sterile liquid pharmaceuticals in all markets. ...
Manufactured by:Cingulate based inKansas City, KANSAS (USA)
CTx-1302 utilizes a breakthrough multi-core formulation of dextroamphetamine, a compound approved by the FDA for the treatment of ...
Manufactured by:Cingulate based inKansas City, KANSAS (USA)
CTx-1301 utilizes a breakthrough multi-core formulation of dexmethylphenidate, a compound approved by the FDA for the treatment of ...
Manufactured by:Cingulate based inKansas City, KANSAS (USA)
Cingulate is developing ADHD medications capable of achieving precise once-daily dosing using a novel erosion based controlled release technology that provides unrivaled control of drug release. ...
by:Otomagnetics, Inc. based inGaithersburg, MARYLAND (USA)
Otomagnetics is developing and commercializing a magnetic injection delivery system that will be able to safely, effectively, and non-invasively deliver therapy to targets in the body that are currently not effectively reached by the standards-of-care, or that may otherwise require surgery to ...
Manufactured by:Vivesto AB based inSolna, SWEDEN
Many intravenously delivered Active Pharmaceutical Ingredients (APIs) are insoluble or poorly soluble in water. This can be a major hurdle in pharmaceutical development and may cause promising drugs to fail during the development process and may limit the application of approved drugs because of poor solubility. According to some estimates, between 70 and 90% of drugs in the development pipeline ...
Manufactured by:Sartorius AG based inGoettingen, GERMANY
Innovation is at the heart of everything we do. Our proprietary drug delivery technology platform, Veltis®, uses engineered recombinant albumin to enhance albumin’s intrinsic characteristics for optimal therapeutic performance of your ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Tyroserleutide hydrochloride is a tripeptide isolated from the degradation products of porcine spleen with antitumor activity. Tyroserleutide hydrochloride can upregulate the expression of the tumor suppressor gene PTEN and inhibit the activity of AKT and PDK1. Tyroserleutide hydrochloride inhibits tumor cell proliferation and MDM2 phosphorylation by inhibiting the PI3K/AKT pathway, and also ...